Boston Scientific Other Working Capital increased by 140.0% to $20.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 61.5%, from $52.00M to $20.00M. Over 3 years (FY 2021 to FY 2025), Other Working Capital shows a downward trend with a -18.6% CAGR.
Positive changes suggest a source of cash from optimizing minor balance sheet items, while negative changes indicate cash is being tied up in these categories.
The aggregate net change in miscellaneous operating assets and liabilities not specifically categorized in major line it...
This is often used to reconcile net income to cash flow and varies based on a company's specific accounting classifications for 'other' items.
cf_change_in_other_working_capital| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $19.50M | $19.50M | $19.50M | $31.25M | $31.25M | $31.25M | $31.25M | -$2.00M | $25.00M | -$4.00M | $12.00M | $14.00M | $52.00M | -$7.00M | $79.00M | -$50.00M | $20.00M |
| QoQ Change | — | +0.0% | +0.0% | +60.3% | +0.0% | +0.0% | +0.0% | -106.4% | >999% | -116.0% | +400.0% | +16.7% | +271.4% | -113.5% | >999% | -163.3% | +140.0% |
| YoY Change | — | — | — | — | +60.3% | +60.3% | +60.3% | -106.4% | -20.0% | -100.0% | -52.0% | — | — | -75.0% | +558.3% | -457.1% | -61.5% |